Maxim Group Downgrades CorMedix (CRMD) to Hold
Tweet Send to a Friend
Maxim Group downgraded CorMedix (NYSE: CRMD) from Buy to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
